Opendata, web and dolomites
Horizon2020 projects coordinated by "FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON"
| # | ||||
|---|---|---|---|---|
| 1 | CSC-IS Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system. | 2015 | 150˙000.00 | 150˙000.00 |
| 2 | MOTRICOLOR Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) | 2015 | 5˙996˙992.00 | 5˙996˙992.00 |
| 3 | GBM-CPP Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 | 147˙750.00 | 147˙750.00 |
| 4 | WNT AND CRC Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors | 2017 | 170˙121.00 | 170˙121.00 |
| 5 | SYST-IMYC Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 | 148˙875.00 | 148˙875.00 |
| 6 | AR-DDR Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer | 2019 | 172˙932.00 | 172˙932.00 |
More Horizon 2020 projects
The Institution FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON has been involved also in the following Horizon 2020 projects.
- MEDBIOINFORMATICS (2015, participant)
- PHD (2015, participant)
- NOCANTHER (2016, participant)
- HARMONY (2017, participant)
- EDIREX (2018, participant)
- MESI-STRAT (2018, participant)
- COLOSSUS (2018, participant)
- LEGACY (2019, participant)
- EUCANCAN (2019, participant)
- IMMUNE-IMAGE (2019, participant)
- ONCNGS (2020, participant)